A. P. A. THEOCHARIDES ET AL: 'Disruption of SIRP  signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts' BLOOD vol. 119, no. 18, 03 September 2012, pages 4333 - 1899, XP055126663 DOI: 10.1182/blood-2011-11-391367 ISSN: 0006-4971 (B1)

IDE K ET AL: "Role for CD47-SIRP[alpha] signaling in xenograft rejection by macrophages", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 104, no. 12, 20 March 2007 (2007-03-20), pages 5062-5066, XP002608756, ISSN: 0027-8424, DOI: 10.1073/PNAS.0609661104 [retrieved on 2007-03-12] (B1)

JAISWAL S. ET AL: 'CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis' CELL vol. 138, no. 2, 24 July 2009, pages 271 - 285, XP009160236 (B1)

KATSUTO TAKENAKA ET AL: "Polymorphism in Sira modulates engraftment of human hematopoietic stem cells", NATURE IMMUNOLOGY, NATURE PUBLISHING GROUP, GB, vol. 8, no. 12, 1 December 2007 (2007-12-01), pages 1313-1323, XP008133576, ISSN: 1529-2908, DOI: 10.1038/NI1527 [retrieved on 2007-11-04] (B1)

MAJETI R. ET AL: 'CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells' CELL vol. 138, no. 2, 24 July 2009, pages 286 - 299, XP002632714 (B1)

MATOZAKI T ET AL: "Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway", TRENDS IN CELL BIOLOGY, ELSEVIER SCIENCE LTD, XX, vol. 19, no. 2, 1 February 2009 (2009-02-01), pages 72-80, XP025913010, ISSN: 0962-8924, DOI: 10.1016/J.TCB.2008.12.001 [retrieved on 2009-01-12] (B1)

WO-A1-99/40940 (B1)

RITCHIE D.S. ET AL: 'A new therapeutic target for leukemia comes to the surface' CELL vol. 138, no. 2, 24 July 2009, pages 226 - 228, XP008161804 (B1)

S. FLORIAN: "Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRP ), CD47, and SHP-1", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 77, no. 6, 9 March 2005 (2005-03-09), pages 984-992, XP55036380, ISSN: 0741-5400, DOI: 10.1189/jlb.0604349 (B1)

WO-A1-2009/046541 (B1)

WO-A1-2009/091547 (B1)

WO-A1-2009/091601 (B1)

RAVINDRA MAJETI1 ET AL: "CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells", DEVELOPMENTAL CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 138, no. 2, 23 July 2009 (2009-07-23) , pages 286-299, XP002632714, ISSN: 1097-4172, DOI: 10.1016/J.CELL.2009.05.045 [retrieved on 2009-07-23] (B1)